A Multi-Center Prospective Non-Interventional Study of Real-World Effectiveness of Etrasimod in Patients with Ulcerative Colitis (ENDEAVOUR-UC)

Brief description of study

The purpose of this research study is to observe the effectiveness of Etrasimod (Velsipity®) in adults with moderately to severely active ulcerative colitis (UC).

The study consists of 52-weeks of follow-up from etrasimod initiation and an additional 28-day safety follow-up period.


Clinical Study Identifier: s24-00435
ClinicalTrials.gov Identifier: NCT06398626
Principal Investigator: Jordan E Axelrad.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.